Non-neuronal cells in amyotrophic lateral sclerosis—from pathogenesis to biomarkers

BF Vahsen, E Gray, AG Thompson, O Ansorge… - Nature Reviews …, 2021 - nature.com
The prevailing motor neuron-centric view of amyotrophic lateral sclerosis (ALS)
pathogenesis could be an important factor in the failure to identify disease-modifying therapy …

[HTML][HTML] Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation

E Giacomelli, BF Vahsen, EL Calder, Y Xu, J Scaber… - Cell Stem Cell, 2022 - cell.com
Neurodegenerative diseases are characterized by progressive cell loss leading to disruption
of the structure and function of the central nervous system. Amyotrophic lateral sclerosis …

C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9

BF Vahsen, S Nalluru, GR Morgan, L Farrimond… - Nature …, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by
progressive motor neuron loss, with additional pathophysiological involvement of non …

Applications of brain organoids in neurodevelopment and neurological diseases

N Sun, X Meng, Y Liu, D Song, C Jiang… - Journal of Biomedical …, 2021 - Springer
A brain organoid is a self-organizing three-dimensional tissue derived from human
embryonic stem cells or pluripotent stem cells and is able to simulate the architecture and …

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

AG Thompson, E Gray, N Verber, Y Bobeva… - Brain …, 2022 - academic.oup.com
The routine clinical integration of individualized objective markers of disease activity in those
diagnosed with the neurodegenerative disorder amyotrophic lateral sclerosis is a key …

CSF chitinase proteins in amyotrophic lateral sclerosis

AG Thompson, E Gray, A Bampton… - Journal of Neurology …, 2019 - jnnp.bmj.com
Objective To evaluate the classifier performance, clinical and biochemical correlations of
cerebrospinal fluid (CSF) levels of the chitinase proteins Chitotriosidase-1 (CHIT1) …

A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS

UG Vijayakumar, V Milla, MY Cynthia Stafford… - Frontiers in …, 2019 - frontiersin.org
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is an incurable
neurodegenerative condition, characterized by the loss of upper and lower motor neurons. It …

Imaging cerebral activity in amyotrophic lateral sclerosis

M Proudfoot, P Bede, MR Turner - Frontiers in neurology, 2019 - frontiersin.org
Advances in neuroimaging, complementing histopathological insights, have established a
multi-system involvement of cerebral networks beyond the traditional neuromuscular …

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis

AG Thompson, K Talbot, MR Turner - Journal of Neurology …, 2022 - jnnp.bmj.com
Background Premorbid body mass index, physical activity, diabetes and cardiovascular
disease have been associated with an altered risk of developing amyotrophic lateral …

Categorization of the amyotrophic lateral sclerosis population via the clinical determinant of post‐onset ΔFS for study design and medical practice

AC Ludolph, P Corcia, C Desnuelle… - Muscle & …, 2024 - Wiley Online Library
The amyotrophic lateral sclerosis (ALS) functional rating scale‐revised (ALSFRS‐R) has
become the most widely utilized measure of disease severity in patients with ALS, with …